EPTIFIBATIDE Side Effects

6931253-3 | Cerebral Haemorrhage
on Aug 04, 2010 Male patient from CROATIA (local name: Hrvatska) , 66 years of age, weighting 231.5 lb, was diagnosed with percutaneous coronary intervention and was treated with Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral haemorrhage. Eptifibatide dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6831253-8 | Thrombocytopenia
Patient was taking Eptifibatide (View Usage). Patient had the following side effects: thrombocytopenia on Jul 09, 2010 from UNITED STATES Additional patient health information: Male patient , 74 years of age, weighting 152.1 lb, was diagnosed with coronary arterial stent insertion and. Eptifibatide dosage: 2mcg/kg/min Every Day Iv. Patient was hospitalized.

6816105-1 | Thrombocytopenia
Adverse event was reported on Jul 02, 2010 by a Male patient taking Eptifibatide (View Usage) (Dosage: ) . Location: UNITED STATES , 49 years of age, weighting 231.5 lb, After Eptifibatide was administered, patient had the following side effects: thrombocytopenia.

6796247-X | Anaemia, Gastric Haemorrhage, Hypotension
on Jun 24, 2010 Male patient from UNITED STATES , 67 years of age, weighting 167.6 lb, was diagnosed with coronary arterial stent insertion and was treated with Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, gastric haemorrhage, hypotension. Eptifibatide dosage: Iv.


6504579-5 | Multi-organ Failure, Pulmonary Congestion, Pulmonary Haemorrhage
on Dec 08, 2009 Male patient from UNITED STATES , 73 years of age, was diagnosed with percutaneous coronary intervention and was treated with Eptifibatide (View Usage). Patient had the following side effects: multi-organ failure, pulmonary congestion, pulmonary haemorrhage. Eptifibatide dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ).

6381379-0 | Bradycardia, Hypotension, Pyrexia, Thrombocytopenia
Patient was taking Eptifibatide (View Usage). After Eptifibatide was administered, patient had the following side effects: bradycardia, hypotension, pyrexia, thrombocytopenia on Sep 14, 2009 from FRANCE Additional patient health information: Male patient , 55 years of age, was diagnosed with acute coronary syndrome and. Eptifibatide dosage: 180 Mcg/kg;once ; 2 Mcg/kg. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), HEPARIN (View Heparin Review and Heparin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ).

6377080-X | Haematocrit Decreased, Haemoglobin Decreased, Haemoptysis, Left Ventricular Dysfunction, Pulmonary Haemorrhage, Pulmonary Oedema, Ventricular Hypertrophy
Adverse event was reported on Sep 23, 2009 by a Male patient taking Eptifibatide (View Usage) (Dosage: 7.9 Ml Once Iv) . Location: UNITED STATES , 67 years of age, weighting 199.1 lb, Patient experienced the following unwanted or unexpected effects: haematocrit decreased, haemoglobin decreased, haemoptysis, left ventricular dysfunction, pulmonary haemorrhage, pulmonary oedema, ventricular hypertrophy. During the same period patient was treated with HEPARIN SODIUM 1,000 UNITS IN SODIUM CHLORIDE 0.9% (1000 Units Per Hour Iv) (View Heparin Sodium 1,000 Units In Sodium Chloride 0.9% Review and Heparin Sodium 1,000 Units In Sodium Chloride 0.9% Label ). Patient was hospitalized.

6322548-5 | Anti-platelet Antibody Positive, Melaena, Thrombocytopenia
on Aug 21, 2009 Male patient from UNITED STATES , 77 years of age, was diagnosed with coronary arterial stent insertion and was treated with Eptifibatide (View Usage). Patient had the following side effects: anti-platelet antibody positive, melaena, thrombocytopenia. Eptifibatide dosage: . Patient was hospitalized.

6210748-4 | Platelet Factor 4 Decreased
on May 28, 2009 Male patient from UNITED STATES , weighting 145.3 lb, was diagnosed with percutaneous coronary intervention and was treated with Eptifibatide (View Usage). After Eptifibatide was administered, patient had the following side effects: platelet factor 4 decreased. Eptifibatide dosage: Iv. During the same period patient was treated with HEPARIN (Iv) (View Heparin Review and Heparin Label ). Patient was hospitalized.

6170962-3 | Haemoglobin Decreased, Infusion Related Reaction, Rectal Haemorrhage
Patient was taking Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: haemoglobin decreased, infusion related reaction, rectal haemorrhage on Apr 27, 2009 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 205.0 lb, was diagnosed with percutaneous coronary intervention and. Eptifibatide dosage: 1 Mcg/kg/ Min Iv. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), INSULIN (View Insulin Review and Insulin Label ), HEPARIN (View Heparin Review and Heparin Label ).

6093464-1 | Pulmonary Alveolar Haemorrhage
Adverse event was reported on Feb 23, 2009 by a Male patient taking Eptifibatide (View Usage) (Dosage: 2 Mcg/kg/min) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 62 years of age, Patient had the following side effects: pulmonary alveolar haemorrhage. During the same period patient was treated with . (View . Review and . Label ). Patient was hospitalized and became disabled.

6028540-2 | Asthenia, Gastric Haemorrhage, Haematemesis, Melaena, Nausea
on Dec 31, 2008 Male patient from UNITED STATES , 60 years of age, was diagnosed with coronary arterial stent insertion and was treated with Eptifibatide (View Usage). After Eptifibatide was administered, patient had the following side effects: asthenia, gastric haemorrhage, haematemesis, melaena, nausea (What is nausea?). Eptifibatide dosage: . During the same period patient was treated with CLOPIDOGREL (75 Mg Every Day Po) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5932917-0 | Nonspecific Reaction, Platelet Count Decreased
on Oct 27, 2008 Male patient from UNITED STATES , 67 years of age, weighting 205.0 lb, was diagnosed with percutaneous coronary intervention and was treated with Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: nonspecific reaction, platelet count decreased. Eptifibatide dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ).

5812539-2 | Troponin Increased
Patient was taking Eptifibatide (View Usage). Patient had the following side effects: troponin increased on Jul 14, 2008 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with myocardial infarction and. Eptifibatide dosage: 180mcg/kg Q10minn Twice Iv, 2mcg/kg/min Continuous Iv Drip.

5763804-9 | Anaemia, Gastrointestinal Haemorrhage, Haematuria
Adverse event was reported on Jun 06, 2008 by a Male patient taking Eptifibatide (View Usage) (Dosage: 4.6 Ml Per Hour Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 75 years of age, weighting 185.2 lb, After Eptifibatide was administered, patient had the following side effects: anaemia, gastrointestinal haemorrhage, haematuria. During the same period patient was treated with ENOXAPARIN SODIUM (120 Mg Every Day Sq) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ). Patient was hospitalized.

5717449-7 | Anaemia Postoperative, Muscle Haemorrhage, Post Procedural Haemorrhage, Retroperitoneal Haematoma
on Apr 24, 2008 Male patient from UNITED STATES , 58 years of age, weighting 231.5 lb, was treated with Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia postoperative, muscle haemorrhage, post procedural haemorrhage, retroperitoneal haematoma. Eptifibatide dosage: . During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5715718-8 | Bradycardia, Contraindication To Medical Treatment, Haematoma, Hypotension, Upper Gastrointestinal Haemorrhage
on Apr 23, 2008 Male patient from UNITED STATES , 76 years of age, weighting 212.5 lb, was diagnosed with angioplasty (What is angioplasty?) and was treated with Eptifibatide (View Usage). Patient had the following side effects: bradycardia, contraindication to medical treatment, haematoma, hypotension, upper gastrointestinal haemorrhage. Eptifibatide dosage: . During the same period patient was treated with HEPARIN (7500 Units Once Iv) (View Heparin Review and Heparin Label ). Patient was hospitalized.

5679823-7 | Angioedema, Dysphagia, Hypersensitivity
Patient was taking Eptifibatide (View Usage). After Eptifibatide was administered, patient had the following side effects: angioedema, dysphagia, hypersensitivity on Mar 18, 2008 from UNITED STATES Additional patient health information: Female patient , 60 years of age, weighting 154.4 lb, was diagnosed with coronary artery thrombosis, percutaneous coronary intervention and. Eptifibatide dosage: 2 Mcg/kg; Iv. During the same period patient was treated with CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), BIVALIRUDIN (View Bivalirudin Review and Bivalirudin Label ). Patient was hospitalized.

5642801-8 | Gastric Haemorrhage
Adverse event was reported on Feb 27, 2008 by a Male patient taking Eptifibatide (View Usage) (Dosage: 75mg Once Iv) was diagnosed with coronary arterial stent insertion and. Location: UNITED STATES , 62 years of age, weighting 207.5 lb, Patient experienced the following unwanted or unexpected effects: gastric haemorrhage. During the same period patient was treated with ENOXAPARIN (100mg Bid Sq) (View Enoxaparin Review and Enoxaparin Label ). Patient was hospitalized.

5533274-4 | Asthenia, Atrial Fibrillation, Atrioventricular Block Complete, Bradycardia, Dizziness
on Nov 27, 2007 Male patient from CANADA , 78 years of age, was diagnosed with acute coronary syndrome and was treated with Eptifibatide (View Usage). Patient had the following side effects: asthenia, atrial fibrillation (What is atrial fibrillation?), atrioventricular block complete, bradycardia, dizziness (What is dizziness?). Eptifibatide dosage: 6ml Twenty Four Times Per Day. During the same period patient was treated with CARVEDILOL (25mg Twice Per Day) (View Carvedilol Review and Carvedilol Label ), AMLODIPINE (10mg Per Day) (View Amlodipine Review and Amlodipine Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATORVASTATIN (View Atorvastatin Review and Atorvastatin Label ). Patient was hospitalized.

5526428-4 | Haemorrhage, Thrombocytopenia
on Nov 21, 2007 Male patient from UNITED STATES , 82 years of age, was treated with Eptifibatide (View Usage). After Eptifibatide was administered, patient had the following side effects: haemorrhage, thrombocytopenia. Eptifibatide dosage: 180mcg Other Iv. During the same period patient was treated with ENOXAPARIN SODIUM (100mg Bid Sq) (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ).

5480583-3 | Haematoma, Haemorrhage, Vascular Pseudoaneurysm
Patient was taking Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: haematoma, haemorrhage, vascular pseudoaneurysm on Oct 02, 2007 from SPAIN Additional patient health information: Female patient , 78 years of age, was diagnosed with acute coronary syndrome and. Eptifibatide dosage: . During the same period patient was treated with HEPARIN (70ml Per Day) (View Heparin Review and Heparin Label ), ACETYLSALICYLIC ACID (100mg Per Day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

5480467-0 | Haematoma, Haemorrhage, Vascular Pseudoaneurysm
Adverse event was reported on Oct 02, 2007 by a Female patient taking Eptifibatide (View Usage) (Dosage: ) was diagnosed with acute coronary syndrome and. Location: SPAIN , 78 years of age, Patient had the following side effects: haematoma, haemorrhage, vascular pseudoaneurysm. During the same period patient was treated with HEPARIN (70ml Per Day) (View Heparin Review and Heparin Label ), ACETYLSALICYLIC ACID (100mg Per Day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), FLUOXETINE (View Fluoxetine Review and Fluoxetine Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ). Patient was hospitalized.

5379435-9 | Chest Discomfort, Dyspnoea Exertional, Thrombosis In Device
on Jun 26, 2007 Female patient from UNITED STATES , 52 years of age, weighting 121.0 lb, was diagnosed with coronary angioplasty and was treated with Eptifibatide (View Usage). After Eptifibatide was administered, patient had the following side effects: chest discomfort, dyspnoea exertional, thrombosis in device. Eptifibatide dosage: . During the same period patient was treated with ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5205831-6 | Pulmonary Alveolar Haemorrhage
on Jan 05, 2007 Female patient from UNITED STATES , 79 years of age, weighting 169.5 lb, was diagnosed with chest pain (What is chest pain?) and was treated with Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary alveolar haemorrhage. Eptifibatide dosage: 180mcg/kg, Once Iv Bolus. During the same period patient was treated with CLOPIDOGREL (75mg Qd Other) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5199618-0 | Thrombocytopenia
Patient was taking Eptifibatide (View Usage). Patient had the following side effects: thrombocytopenia on Jan 02, 2007 from UNITED STATES Additional patient health information: Male patient , 64 years of age, weighting 249.1 lb, was diagnosed with percutaneous coronary intervention and. Eptifibatide dosage: Once Iv. During the same period patient was treated with ALLOPURINOL SODIUM (View Allopurinol Sodium Review and Allopurinol Sodium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BRINZOLAMIDE (View Brinzolamide Review and Brinzolamide Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), DOCUSATE (View Docusate Review and Docusate Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ). Patient was hospitalized and became disabled.

5103200-0 | Thrombocytopenia
Adverse event was reported on Sep 12, 2006 by a Male patient taking Eptifibatide (View Usage) (Dosage: 180 Mcg/kg Bolus, 2mcg/kg/min Infusion Iv) was diagnosed with catheterisation cardiac, stent placement and. Location: UNITED STATES , 54 years of age, weighting 219.8 lb, After Eptifibatide was administered, patient had the following side effects: thrombocytopenia. During the same period patient was treated with . (View . Review and . Label ).

4922099-6 | Atrial Fibrillation, Hypotension, Retroperitoneal Haemorrhage, Tachycardia
on Feb 22, 2006 Female patient from UNITED STATES , 77 years of age, weighting 176.8 lb, was treated with Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), hypotension, retroperitoneal haemorrhage, tachycardia. Eptifibatide dosage: 2mcg/kg/min Iv X 26hr. During the same period patient was treated with ASPIRIN (325 Mg Po Daily) (View Aspirin Review and Aspirin Label ), VICODIN (View Vicodin Review and Vicodin Label ), RYTHMOL (View Rythmol Review and Rythmol Label ), ACCUPRIL (View Accupril Review and Accupril Label ), PREVACID (View Prevacid Review and Prevacid Label ), XANAX (View Xanax Review and Xanax Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

4850788-0 | Thrombocytopenia
on Dec 08, 2005 Male patient from UNITED STATES , 47 years of age, was treated with Eptifibatide (View Usage). Patient had the following side effects: thrombocytopenia. Eptifibatide dosage: . Patient was hospitalized.

4809907-4 | Duodenitis, Gastritis Erosive, Haematochezia, Haematocrit Decreased, Post Procedural Complication
Patient was taking Eptifibatide (View Usage). After Eptifibatide was administered, patient had the following side effects: duodenitis, gastritis erosive, haematochezia, haematocrit decreased, post procedural complication on Oct 24, 2005 from UNITED STATES Additional patient health information: Male patient , 70 years of age, . Eptifibatide dosage: 2mcg/kg/min. During the same period patient was treated with HEPARIN (600units/hr) (View Heparin Review and Heparin Label ). Patient was hospitalized.

4802750-1 | Thrombocytopenia
Adverse event was reported on Oct 17, 2005 by a Female patient taking Eptifibatide (View Usage) (Dosage: 180mcg/kg Bolus, 2mcg/kg/min Iv) . Location: UNITED STATES , 64 years of age, weighting 284.0 lb, Patient experienced the following unwanted or unexpected effects: thrombocytopenia. During the same period patient was treated with HEPARIN (9600 Unit Bolus, 12unit/kg/hr) (View Heparin Review and Heparin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), FOSINOPRIL SODIUM (View Fosinopril Sodium Review and Fosinopril Sodium Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), TRIGLYCERIDES (View Triglycerides Review and Triglycerides Label ). Patient was hospitalized.

4789496-3 | Catheter Site Haematoma, Post Procedural Complication
on Oct 05, 2005 Female patient from UNITED STATES , 65 years of age, weighting 564.4 lb, was diagnosed with acute myocardial infarction and was treated with Eptifibatide (View Usage). Patient had the following side effects: catheter site haematoma, post procedural complication. Eptifibatide dosage: 180 Mcg/kg Bolus 2mcg/kg/min. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), HEPARIN (View Heparin Review and Heparin Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

4614846-8 | Platelet Count Decreased
on Mar 18, 2005 Male patient from , 81 years of age, was diagnosed with myocardial infarction and was treated with Eptifibatide (View Usage). After Eptifibatide was administered, patient had the following side effects: platelet count decreased. Eptifibatide dosage: 2mcg/kg/min Iv. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), NITRO (View Nitro Review and Nitro Label ), BB (View Bb Review and Bb Label ), ACE INH (View Ace Inh Review and Ace Inh Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PLAVIX (View Plavix Review and Plavix Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ).

4578375-2 | Acute Myocardial Infarction, Thrombocytopenia
Patient was taking Eptifibatide (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, thrombocytopenia on Feb 02, 2005 from Additional patient health information: Male patient , 70 years of age, was diagnosed with myocardial infarction and. Eptifibatide dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), QUINAPRIL (View Quinapril Review and Quinapril Label ), PLAVIX (View Plavix Review and Plavix Label ), ASP (View Asp Review and Asp Label ), LIPITOR (View Lipitor Review and Lipitor Label ), NORVASC (View Norvasc Review and Norvasc Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ). Patient was hospitalized.